ARTICLE | Company News
Life Technologies sales and marketing update
October 1, 2012 7:00 AM UTC
Life Technologies launched its Pervenio Lung RS test in the U.S. to determine whether an early stage, non-squamous, non-small cell lung cancer (NSCLC) patient is at high, intermediate or low risk of ...